1. Home
  2. CDTX vs MCHX Comparison

CDTX vs MCHX Comparison

Compare CDTX & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDTX
  • MCHX
  • Stock Information
  • Founded
  • CDTX 2012
  • MCHX 2003
  • Country
  • CDTX United States
  • MCHX United States
  • Employees
  • CDTX N/A
  • MCHX N/A
  • Industry
  • CDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • MCHX Business Services
  • Sector
  • CDTX Health Care
  • MCHX Consumer Discretionary
  • Exchange
  • CDTX Nasdaq
  • MCHX Nasdaq
  • Market Cap
  • CDTX 79.3M
  • MCHX 79.9M
  • IPO Year
  • CDTX 2015
  • MCHX 2004
  • Fundamental
  • Price
  • CDTX $14.37
  • MCHX $1.70
  • Analyst Decision
  • CDTX Strong Buy
  • MCHX
  • Analyst Count
  • CDTX 5
  • MCHX 0
  • Target Price
  • CDTX $30.50
  • MCHX N/A
  • AVG Volume (30 Days)
  • CDTX 21.1K
  • MCHX 33.5K
  • Earning Date
  • CDTX 11-07-2024
  • MCHX 10-31-2024
  • Dividend Yield
  • CDTX N/A
  • MCHX N/A
  • EPS Growth
  • CDTX N/A
  • MCHX N/A
  • EPS
  • CDTX N/A
  • MCHX N/A
  • Revenue
  • CDTX $44,653,000.00
  • MCHX $48,594,000.00
  • Revenue This Year
  • CDTX N/A
  • MCHX N/A
  • Revenue Next Year
  • CDTX N/A
  • MCHX $4.20
  • P/E Ratio
  • CDTX N/A
  • MCHX N/A
  • Revenue Growth
  • CDTX 19.60
  • MCHX N/A
  • 52 Week Low
  • CDTX $10.00
  • MCHX $1.11
  • 52 Week High
  • CDTX $24.40
  • MCHX $2.15
  • Technical
  • Relative Strength Index (RSI)
  • CDTX 72.85
  • MCHX 45.01
  • Support Level
  • CDTX $12.89
  • MCHX $1.67
  • Resistance Level
  • CDTX $13.78
  • MCHX $1.90
  • Average True Range (ATR)
  • CDTX 0.70
  • MCHX 0.13
  • MACD
  • CDTX 0.13
  • MCHX -0.00
  • Stochastic Oscillator
  • CDTX 75.31
  • MCHX 33.33

About CDTX Cidara Therapeutics Inc.

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

Share on Social Networks: